An Early Canadian Experience With the Correx Automated Coring and Apical Connector Device for Aortic Valve Bypass.
| Autor: | Al-Amodi HA; From the *Schulich School of Medicine, Western University, London, ON Canada; and †Division of Cardiac Surgery, University of Western Ontario, Lawson Health Research Institute, London, ON Canada., Tarola CL, Alhabib HF, Adams C, Guo LR, Kiaii BB |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Innovations (Philadelphia, Pa.) [Innovations (Phila)] 2016 Nov/Dec; Vol. 11 (6), pp. 434-438. |
| DOI: | 10.1097/IMI.0000000000000322 |
| Abstrakt: | Objective: Aortic valve replacement is the standard of care for severe, symptomatic aortic valve stenosis (AS); however, anatomy or pre-existing comorbidities may preclude conventional or alternative transcatheter approaches. Aortic valve bypass (AVB) may be performed as a salvage procedure for the relief of symptomatic aortic stenosis in patients who are not suitable candidates for aortic valve replacement. Methods: At our institution, seven patients underwent AVB using the Correx automated coring and apical connector system. All patients had severe AS with New York Heart Association functional class 3 symptoms and were not candidates for conventional or transcatheter approaches. Via a left anterolateral thoracotomy to access the descending aorta and left ventricular apex, we used the Correx system (Correx, Waltham, MA USA) to anastomose a valve conduit to the left ventricular apex proximally and the descending aorta distally. Three patients required cardiopulmonary bypass. Results: In all seven patients, the automated coring and apical connector was successfully deployed. There were two in-hospital deaths in this series. Immediately postoperatively and at 3 months, there was a significant reduction in mean and peak valve gradients, and all surviving patients performed at New York Heart Association functional class 1. Conclusions: Aortic valve bypass seems to be an acceptable alternative for the treatment of severe AS in high-risk patients who are not candidates for aortic valve replacement. The Correx automated system may improve the clinical applicability and surgical reproducibility of AVB in appropriately selected patients in which conventional or transcatheter aortic valve replacement is not a feasible options. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|